A comprehensive review of the influence of Epigallocatechin gallate on Sjögren's syndrome associated molecular regulators of exocytosis (Review)
- Authors:
- Abdelmounaim Errachid
- Michal Nohawica
- Marzena Wyganowska‑Swiatkowska
-
Affiliations: Department of Dental Surgery and Periodontology, Poznan University of Medicinal Sciences, 60‑812 Poznań, Greater Poland, Poland - Published online on: September 21, 2021 https://doi.org/10.3892/br.2021.1471
- Article Number: 95
-
Copyright: © Errachid et al. This is an open access article distributed under the terms of Creative Commons Attribution License.
This article is mentioned in:
Abstract
 |
 |
 |
|
Liu J and Duan Y: Saliva: A potential media for disease diagnostics and monitoring. Oral Oncol. 48:569–577. 2012.PubMed/NCBI View Article : Google Scholar | |
|
Chiappin S, Antonelli G, Gatti R and De Palo EF: Saliva specimen: A new laboratory tool for diagnostic and basic investigation. Clin Chim Acta. 383:30–40. 2007.PubMed/NCBI View Article : Google Scholar | |
|
Karnati R, Laurie DE and Laurie GW: Lacritin and the tear proteome as natural replacement therapy for dry eye. Exp Eye Res. 117:39–52. 2013.PubMed/NCBI View Article : Google Scholar | |
|
Sitaramamma T, Shivaji S and Rao GN: Effect of storage on protein concentration of tear samples. Curr Eye Res. 17:1027–1035. 1998.PubMed/NCBI View Article : Google Scholar | |
|
Wilmarth PA, Riviere MA, Rustvold DL, Lauten JD, Madden TE and David LL: Two-dimensional liquid chromatography study of the human whole saliva proteome. J Proteome Res. 3:1017–1023. 2004.PubMed/NCBI View Article : Google Scholar | |
|
Humphrey SP and Williamson RT: A review of saliva: Normal composition, flow, and function. J Prosthet Dent. 85:162–169. 2001.PubMed/NCBI View Article : Google Scholar | |
|
Tucker AS: Salivary gland development. Semin Cell Dev Biol. 18:237–244. 2007.PubMed/NCBI View Article : Google Scholar | |
|
Br H and Mp H: Regulatory mechanisms driving salivary gland organogenesis. Curr Top Dev Biol. 115:111–130. 2015.PubMed/NCBI View Article : Google Scholar | |
|
Voulgarelis M and Tzioufas AG: Pathogenetic mechanisms in the initiation and perpetuation of Sjögren's syndrome. Nat Rev Rheumatol. 6:529–537. 2010.PubMed/NCBI View Article : Google Scholar | |
|
Mavragani CP and Moutsopoulos HM: The geoepidemiology of Sjögren's syndrome. Autoimmun Rev. 9:A305–A310. 2010.PubMed/NCBI View Article : Google Scholar | |
|
Busamia B, Gonzalez-Moles MA, Ruiz-Avila I, Brunotto M, Gil-Montoya JA, Bravo M, Gobbi C and Finkelberg A: Cell apoptosis and proliferation in salivary glands of Sjögren's syndrome. J Oral Pathol Med. 40:721–725. 2011.PubMed/NCBI View Article : Google Scholar | |
|
Pedersen AM, Dissing S, Fahrenkrug J, Hannibal J, Reibel J and Nauntofte B: Innervation pattern and Ca2+ signalling in labial salivary glands of healthy individuals and patients with primary Sjögren's syndrome (pSS). J Oral Pathol Med. 29:97–109. 2000.PubMed/NCBI View Article : Google Scholar | |
|
Zoukhri D and Kublin CL: Impaired neurotransmitter release from lacrimal and salivary gland nerves of a murine model of Sjögren's syndrome. Invest Ophthalmol Vis Sci. 42:925–932. 2001.PubMed/NCBI | |
|
Dawson LJ, Stanbury J, Venn N, Hasdimir B, Rogers SN and Smith PM: Antimuscarinic antibodies in primary Sjögren's syndrome reversibly inhibit the mechanism of fluid secretion by human submandibular salivary acinar cells. Arthritis Rheum. 54:1165–1173. 2006.PubMed/NCBI View Article : Google Scholar | |
|
Caulfield VL, Balmer C, Dawson LJ and Smith PM: A role for nitric oxide-mediated glandular hypofunction in a non-apoptotic model for Sjogren's syndrome. Rheumatology (Oxford). 48:727–733. 2009.PubMed/NCBI View Article : Google Scholar | |
|
Dawson LJ, Fox PC and Smith PM: Sjogrens syndrome-the non-apoptotic model of glandular hypofunction. Rheumatology (Oxford). 45:792–798. 2006.PubMed/NCBI View Article : Google Scholar | |
|
Soyfoo MS, Vriese CD, Debaix H, Martin-Martinez MD, Mathieu C, Devuyst O, Steinfeld SD and Delporte C: Modified aquaporin 5 expression and distribution in submandibular glands from NOD mice displaying autoimmune exocrinopathy. Arthritis Rheum. 56:2566–2574. 2007.PubMed/NCBI View Article : Google Scholar | |
|
Aktas O, Prozorovski T, Smorodchenko A, Savaskan NE, Lauster R, Kloetzel PM, Infante-Duarte C, Brocke S and Zipp F: Green tea epigallocatechin-3-gallate mediates T cellular NF-kappa B inhibition and exerts neuroprotection in autoimmune encephalomyelitis. J Immunol. 173:5794–5800. 2004.PubMed/NCBI View Article : Google Scholar | |
|
Gillespie K, Kodani I, Dickinson DP, Ogbureke KU, Camba AM, Wu M, Looney S, Chu TC, Qin H, Bisch F, et al: Effects of oral consumption of the green tea polyphenol EGCG in a murine model for human Sjogren's syndrome, an autoimmune disease. Life Sci. 83:581–588. 2008.PubMed/NCBI View Article : Google Scholar | |
|
Dickinson D, Yu H, Ohno S, Thomas C, Derossi S, Ma YH, Yates N, Hahn E, Bisch F, Yamamoto T and Hsu S: Epigallocatechin-3-gallate prevents autoimmune-associated down- regulation of p21 in salivary gland cells through a p53-independent pathway. Inflamm Allergy Drug Targets. 13:15–24. 2014.PubMed/NCBI View Article : Google Scholar | |
|
Carsons S: A review and update of Sjögren's syndrome: Manifestations, diagnosis, and treatment. Am J Manag Care. 7:S433–443. 2001.PubMed/NCBI | |
|
Zhang NZ, Shi CS, Yao QP, Pan GX, Wang LL, Wen ZX, Li XC and Dong Y: Prevalence of primary Sjögren's syndrome in China. J Rheumatol. 22:659–661. 1995.PubMed/NCBI | |
|
Ohno S, Yu H, Dickinson D, Chu TC, Ogbureke K, Derossi S, Yamamoto T and Hsu S: Epigallocatechin-3-gallate modulates antioxidant and DNA repair-related proteins in exocrine glands of a primary Sjogren's syndrome mouse model prior to disease onset. Autoimmunity. 45:540–546. 2012.PubMed/NCBI View Article : Google Scholar | |
|
Saito K, Mori S, Date F and Ono M: Epigallocatechin gallate inhibits oxidative stress-induced DNA damage and apoptosis in MRL-Fas(lpr) mice with autoimmune sialadenitis via upregulation of heme oxygenase-1 and Bcl-2. Autoimmunity. 47:13–22. 2014.PubMed/NCBI View Article : Google Scholar | |
|
Hsu S and Dickinson D: A new approach to managing oral manifestations of Sjogren's syndrome and skin manifestations of lupus. J Biochem Mol Biol. 39:229–239. 2006.PubMed/NCBI View Article : Google Scholar | |
|
Hsu S, Dickinson DP, Qin H, Lapp C, Lapp D, Borke J, Walsh DS, Bollag WB, Stöppler H, Yamamoto T, et al: Inhibition of autoantigen expression by (-)-epigallocatechin-3-gallate (the major constituent of green tea) in normal human cells. J Pharmacol Exp Ther. 315:805–811. 2005.PubMed/NCBI View Article : Google Scholar | |
|
Hsu SD, Dickinson DP, Qin H, Borke J, Ogbureke KU, Winger JN, Camba AM, Bollag WB, Stöppler HJ, Sharawy MM and Schuster GS: Green tea polyphenols reduce autoimmune symptoms in a murine model for human Sjogren's syndrome and protect human salivary acinar cells from TNF-alpha-induced cytotoxicity. Autoimmunity. 40:138–147. 2007.PubMed/NCBI View Article : Google Scholar | |
|
Guo T, Song D, Cheng L and Zhang X: Interactions of tea catechins with intestinal microbiota and their implication for human health. Food Sci Biotechnol. 28:1617–1625. 2019.PubMed/NCBI View Article : Google Scholar | |
|
Chiou YS, Wu JC, Huang Q, Shahidi F, Wang YJ, Ho CT and Pan MH: Metabolic and colonic microbiota transformation may enhance the bioactivities of dietary polyphenols. J Funct Foods. 7:3–25. 2014. | |
|
Pervin M, Unno K, Takagaki A, Isemura M and Nakamura Y: Function of green tea catechins in the brain: Epigallocatechin gallate and its metabolites. Int J Mol Sci. 20(3630)2019.PubMed/NCBI View Article : Google Scholar | |
|
Kim HS, Quon MJ and Kim J: New insights into the mechanisms of polyphenols beyond antioxidant properties; lessons from the green tea polyphenol, epigallocatechin 3-gallate. Redox Biology. 2:187–195. 2014.PubMed/NCBI View Article : Google Scholar | |
|
Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, Shamseer L, Tetzlaff JM, Akl EA, Brennan SE, et al: The PRISMA 2020 statement: An updated guideline for reporting systematic reviews. BMJ. 372(n71)2021.PubMed/NCBI View Article : Google Scholar | |
|
Hong W: SNAREs and traffic. Biochim Biophys Acta. 1744:120–144. 2005.PubMed/NCBI View Article : Google Scholar | |
|
Grote E, Hao JC, Bennett MK and Kelly RB: A targeting signal in VAMP regulating transport to synaptic vesicles. Cell. 81:581–589. 1995.PubMed/NCBI View Article : Google Scholar | |
|
Alberts B, Johnson A, Lewis J, Raff M, Roberts K and Walter P: Transport from the ER through the Golgi Apparatus. Molecular Biology of the Cell 4th edition, 2002. | |
|
Whyte JRC and Munro S: Vesicle tethering complexes in membrane traffic. J Cell Sci. 115:2627–2637. 2002.PubMed/NCBI | |
|
Chen YA and Scheller RH: SNARE-mediated membrane fusion. Nat Rev Mol Cell Biol. 2:98–106. 2001.PubMed/NCBI View Article : Google Scholar | |
|
Han J, Pluhackova K and Böckmann RA: The multifaceted role of SNARE proteins in membrane fusion. Front Physiol. 8(5)2017.PubMed/NCBI View Article : Google Scholar | |
|
Srivanitchapoom P, Pandey S and Hallett M: Drooling in Parkinson's Disease: A review. Parkinsonism Relat Disord. 20:1109–1118. 2014.PubMed/NCBI View Article : Google Scholar | |
|
Yu GY, Zhu ZH, Mao C, Cai ZG, Zou LH, Lu L, Zhang L, Peng X, Li N and Huang Z: Microvascular autologous submandibular gland transfer in severe cases of keratoconjunctivitis sicca. Int J Oral Maxillofac Surg. 33:235–239. 2004.PubMed/NCBI View Article : Google Scholar | |
|
Ewert P, Aguilera S, Alliende C, Kwon YJ, Albornoz A, Molina C, Urzúa U, Quest AF, Olea N, Pérez P, et al: Disruption of tight junction structure in salivary glands from Sjögren's syndrome patients is linked to proinflammatory cytokine exposure. Arthritis Rheum. 62:1280–1289. 2010.PubMed/NCBI View Article : Google Scholar | |
|
Wong SH, Zhang T, Xu Y, Subramaniam VN, Griffiths G and Hong W: Endobrevin, a novel synaptobrevin/VAMP-like protein preferentially associated with the early endosome. Mol Biol Cell. 9:1549–1563. 1998.PubMed/NCBI View Article : Google Scholar | |
|
Lang T and Jahn R: Core proteins of the secretory machinery. Handb Exp Pharmacol. 107–127. 2008.PubMed/NCBI View Article : Google Scholar | |
|
Cosen-Binker LI, Binker MG, Wang CC, Hong W and Gaisano HY: VAMP8 is the v-SNARE that mediates basolateral exocytosis in a mouse model of alcoholic pancreatitis. J Clin Invest. 118:2535–2551. 2008.PubMed/NCBI View Article : Google Scholar | |
|
Barrera MJ, Sánchez M, Aguilera S, Alliende C, Bahamondes V, Molina C, Quest AF, Urzúa U, Castro I, González S, et al: Aberrant localization of fusion receptors involved in regulated exocytosis in salivary glands of Sjögren's syndrome patients is linked to ectopic mucin secretion. J Autoimmun. 39:83–92. 2012.PubMed/NCBI View Article : Google Scholar | |
|
Wang CC, Shi H, Guo K, Ng CP, Li J, Gan BQ, Chien Liew H, Leinonen J, Rajaniemi H, et al: VAMP8/endobrevin as a general vesicular SNARE for regulated exocytosis of the exocrine system. Mol Biol Cell. 18:1056–1063. 2007.PubMed/NCBI View Article : Google Scholar | |
|
Wang CC, Ng CP, Lu L, Atlashkin V, Zhang W, Seet LF and Hong W: A role of VAMP8/endobrevin in regulated exocytosis of pancreatic acinar cells. Dev Cell. 7:359–371. 2004.PubMed/NCBI View Article : Google Scholar | |
|
Takuma T, Arakawa T and Tajima Y: Interaction of SNARE proteins in rat parotid acinar cells. Arch Oral Biol. 45:369–375. 2000.PubMed/NCBI View Article : Google Scholar | |
|
Imai A, Nashida T, Yoshie S and Shimomura H: Intracellular localisation of SNARE proteins in rat parotid acinar cells: SNARE complexes on the apical plasma membrane. Arch Oral Biol. 48:597–604. 2003.PubMed/NCBI View Article : Google Scholar | |
|
Stoeckelhuber M, Scherer EQ, Janssen KP, Slotta-Huspenina J, Loeffelbein DJ, Rohleder NH, Nieberler M, Hasler R and Kesting MR: The human submandibular gland: Immunohistochemical analysis of SNAREs and cytoskeletal proteins. J Histochem Cytochem. 60:110–120. 2012.PubMed/NCBI View Article : Google Scholar | |
|
Goicovich E, Molina C, Pérez P, Aguilera S, Fernández J, Olea N, Alliende C, Leyton C, Romo R, Leyton L and González MJ: Enhanced degradation of proteins of the basal lamina and stroma by matrix metalloproteinases from the salivary glands of Sjögren's syndrome patients: Correlation with reduced structural integrity of acini and ducts. Arthritis Rheum. 48:2573–2584. 2003.PubMed/NCBI View Article : Google Scholar | |
|
Coursey TG, Tukler Henriksson J, Barbosa FL, de Paiva CS and Pflugfelder SC: Interferon-γ-induced unfolded protein response in conjunctival goblet cells as a cause of mucin deficiency in Sjögren syndrome. Am J Pathol. 186:1547–1558. 2016.PubMed/NCBI View Article : Google Scholar | |
|
Holt M, Varoqueaux F, Wiederhold K, Takamori S, Urlaub H, Fasshauer D and Jahn R: Identification of SNAP-47, a novel Qbc-SNARE with ubiquitous expression. J Biol Chem. 281:17076–17083. 2006.PubMed/NCBI View Article : Google Scholar | |
|
Wang W, Hart PS, Piesco NP, Lu X, Gorry MC and Hart TC: Aquaporin expression in developing human teeth and selected orofacial tissues. Calcif Tissue Int. 72:222–227. 2003.PubMed/NCBI View Article : Google Scholar | |
|
Gresz V, Kwon TH, Hurley PT, Varga G, Zelles T, Nielsen S, Case RM and Steward MC: Identification and localization of aquaporin water channels in human salivary glands. Am J Physiol Gastrointest Liver Physiol. 281:G247–G254. 2001.PubMed/NCBI View Article : Google Scholar | |
|
Steinfeld S, Cogan E, King LS, Agre P, Kiss R and Delporte C: Abnormal distribution of aquaporin-5 water channel protein in salivary glands from Sjögren's syndrome patients. Lab Invest. 81:143–148. 2001.PubMed/NCBI View Article : Google Scholar | |
|
Krane CM, Melvin JE, Nguyen HV, Richardson L, Towne JE, Doetschman T and Menon AG: Salivary acinar cells from aquaporin 5-deficient mice have decreased membrane water permeability and altered cell volume regulation. J Biol Chem. 276:23413–23420. 2001.PubMed/NCBI View Article : Google Scholar | |
|
Ishikawa Y, Cho G, Yuan Z, Inoue N and Nakae Y: Aquaporin-5 water channel in lipid rafts of rat parotid glands. Biochim Biophys Acta. 1758:1053–1060. 2006.PubMed/NCBI View Article : Google Scholar | |
|
Ishikawa Y, Cho G, Yuan Z, Skowronski MT, Pan Y and Ishida H: Water channels and zymogen granules in salivary glands. J Pharmacol Sci. 100:495–512. 2006.PubMed/NCBI View Article : Google Scholar | |
|
Ishikawa Y, Eguchi T, Skowronski MT and Ishida H: Acetylcholine acts on M3 muscarinic receptors and induces the translocation of aquaporin5 water channel via cytosolic Ca2+ elevation in rat parotid glands. Biochem Biophys Res Commun. 245:835–840. 1998.PubMed/NCBI View Article : Google Scholar | |
|
Xiang B, Zhang Y, Li YM, Zhang K, Zhang YY, Wu LL and Yu GY: Effects of phenylephrine on transplanted submandibular gland. J Dent Res. 85:1106–1111. 2006.PubMed/NCBI View Article : Google Scholar | |
|
Tsubota K, Hirai S, King LS, Agre P and Ishida N: Defective cellular trafficking of lacrimal gland aquaporin-5 in Sjögren's syndrome. Lancet. 357:688–689. 2001.PubMed/NCBI View Article : Google Scholar | |
|
Ma T, Song Y, Gillespie A, Carlson EJ, Epstein CJ and Verkman AS: Defective secretion of saliva in transgenic mice lacking aquaporin-5 water channels. J Biol Chem. 274:20071–20074. 1999.PubMed/NCBI View Article : Google Scholar | |
|
Alam J, Koh JH, Kim N, Kwok SK, Park SH, Song YW, Park K and Choi Y: Detection of autoantibodies against aquaporin-5 in the sera of patients with primary Sjögren's syndrome. Immunol Res. 64:848–856. 2016.PubMed/NCBI View Article : Google Scholar | |
|
Alam J, Koh JH, Kwok SK, Park SH, Park K and Choi Y: Functional Epitopes for Anti-Aquaporin 5 Antibodies in Sjögren Syndrome. J Dent Res. 96:1414–1421. 2017.PubMed/NCBI View Article : Google Scholar | |
|
Xiao L, Ng TB, Feng YB, Yao T, Wong JH, Yao RM, Li L, Mo FZ, Xiao Y, Shaw PC, et al: Dendrobium candidum extract increases the expression of aquaporin-5 in labial glands from patients with Sjögren's syndrome. Phytomedicine. 18:194–198. 2011.PubMed/NCBI View Article : Google Scholar | |
|
Lin X, Shaw PC, Sze SCW, Tong Y and Zhang Y: Dendrobium officinale polysaccharides ameliorate the abnormality of aquaporin 5, pro-inflammatory cytokines and inhibit apoptosis in the experimental Sjögren's syndrome mice. Int Immunopharmacol. 11:2025–2032. 2011.PubMed/NCBI View Article : Google Scholar | |
|
Sart S, Errachid A, Schneider YJ and Agathos SN: Modulation of mesenchymal stem cell actin organization on conventional microcarriers for proliferation and differentiation in stirred bioreactors. J Tissue Eng Regen Med. 7:537–551. 2013.PubMed/NCBI View Article : Google Scholar | |
|
Nashida T, Yoshie S, Imai A and Shimomura H: Presence of cytoskeleton proteins in parotid glands and their roles during secretion. Arch Oral Biol. 49:975–982. 2004.PubMed/NCBI View Article : Google Scholar | |
|
Segawa A, Riva A, Loffredo F, Congiu T, Yamashina S and Testa Riva F: Cytoskeletal regulation of human salivary secretion studied by high resolution electron microscopy and confocal laser microscopy. Eur J Morphol. 36 (Suppl):S41–S45. 1998.PubMed/NCBI | |
|
Perrin D, Möller K, Hanke K and Söling HD: cAMP and Ca(2+)-mediated secretion in parotid acinar cells is associated with reversible changes in the organization of the cytoskeleton. J Cell Biol. 116:127–134. 1992.PubMed/NCBI View Article : Google Scholar | |
|
Valentijn KM, Gumkowski FD and Jamieson JD: The subapical actin cytoskeleton regulates secretion and membrane retrieval in pancreatic acinar cells. J Cell Sci. 112:81–96. 1999.PubMed/NCBI | |
|
Muallem S, Kwiatkowska K, Xu X and Yin HL: Actin filament disassembly is a sufficient final trigger for exocytosis in nonexcitable cells. J Cell Biol. 128:589–598. 1995.PubMed/NCBI View Article : Google Scholar | |
|
Busch L, Sterin-Borda L and Borda E: Differences in the regulatory mechanism of amylase release by rat parotid and submandibular glands. Arch Oral Biol. 47:717–722. 2002.PubMed/NCBI View Article : Google Scholar | |
|
Birkenfeld J, Kartmann B, Betz H and Roth D: Cofilin activation during Ca(2+)-triggered secretion from adrenal chromaffin cells. Biochem Biophys Res Commun. 286:493–498. 2001.PubMed/NCBI View Article : Google Scholar | |
|
Cui L, Elzakra N, Xu S, Xiao GG, Yang Y and Hu S: Investigation of three potential autoantibodies in Sjogren's syndrome and associated MALT lymphoma. Oncotarget. 8:30039–30049. 2017.PubMed/NCBI View Article : Google Scholar | |
|
Zhang Y, Hussain M, Yang X, Chen P, Yang C, Xun Y, Tian Y and Du H: Identification of moesin as a novel autoantigen in patients with Sjögren's syndrome. Protein Pept Lett. 25:350–355. 2018.PubMed/NCBI View Article : Google Scholar | |
|
Mitic LL, Van Itallie CM and Anderson JM: Molecular physiology and pathophysiology of tight junctions I. Tight junction structure and function: Lessons from mutant animals and proteins. Am J Physiol Gastrointest Liver Physiol. 279:G250–G254. 2000.PubMed/NCBI View Article : Google Scholar | |
|
Beguin P, Errachid A, Larondelle Y and Schneider YJ: Effect of polyunsaturated fatty acids on tight junctions in a model of the human intestinal epithelium under normal and inflammatory conditions. Food Funct. 4:923–931. 2013.PubMed/NCBI View Article : Google Scholar | |
|
Flynn AN, Itani OA, Moninger TO and Welsh MJ: Acute regulation of tight junction ion selectivity in human airway epithelia. Proc Natl Acad Sci USA. 106:3591–3596. 2009.PubMed/NCBI View Article : Google Scholar | |
|
Fox RI, Kang HI, Ando D, Abrams J and Pisa E: Cytokine mRNA expression in salivary gland biopsies of Sjögren's syndrome. J Immunol. 152:5532–5539. 1994.PubMed/NCBI | |
|
Fox PC, Grisius MM, Bermudez DK and Sun D: Cytokine mRNA expression in labial salivary glands and cytokine secretion in parotid saliva in Sjögren's syndrome. Adv Exp Med Biol. 438:909–915. 1998.PubMed/NCBI View Article : Google Scholar | |
|
Baker OJ, Camden JM, Redman RS, Jones JE, Seye CI, Erb L and Weisman GA: Proinflammatory cytokines tumor necrosis factor-alpha and interferon-gamma alter tight junction structure and function in the rat parotid gland Par-C10 cell line. Am J Physiol Cell Physiol. 295:C1191–C1201. 2008.PubMed/NCBI View Article : Google Scholar | |
|
Youakim A and Ahdieh M: Interferon-gamma decreases barrier function in T84 cells by reducing ZO-1 levels and disrupting apical actin. Am J Physiol. 276:G1279–G1288. 1999.PubMed/NCBI View Article : Google Scholar | |
|
Ma TY, Iwamoto GK, Hoa NT, Akotia V, Pedram A, Boivin MA and Said HM: TNF-alpha-induced increase in intestinal epithelial tight junction permeability requires NF-kappa B activation. Am J Physiol Gastrointest Liver Physiol. 286:G367–376. 2004.PubMed/NCBI View Article : Google Scholar | |
|
Mankertz J, Tavalali S, Schmitz H, Mankertz A, Riecken EO, Fromm M and Schulzke JD: Expression from the human occludin promoter is affected by tumor necrosis factor alpha and interferon gamma. J Cell Sci. 113:2085–2090. 2000.PubMed/NCBI | |
|
Utech M, Ivanov AI, Samarin SN, Bruewer M, Turner JR, Mrsny RJ, Parkos CA and Nusrat A: Mechanism of IFN-gamma-induced endocytosis of tight junction proteins: Myosin II-dependent vacuolarization of the apical plasma membrane. Mol Biol Cell. 16:5040–5052. 2005.PubMed/NCBI View Article : Google Scholar | |
|
Manoussakis MN and Kapsogeorgou EK: The role of epithelial cells in the pathogenesis of Sjögren's syndrome. Clin Rev Allergy Immunol. 32:225–230. 2007.PubMed/NCBI View Article : Google Scholar | |
|
Kawedia JD, Nieman ML, Boivin GP, Melvin JE, Kikuchi K, Hand AR, Lorenz JN and Menon AG: Interaction between transcellular and paracellular water transport pathways through Aquaporin 5 and the tight junction complex. Proc Natl Acad Sci USA. 104:3621–3626. 2007.PubMed/NCBI View Article : Google Scholar | |
|
Ichiyama T, Nakatani E, Tatsumi K, Hideshima K, Urano T, Nariai Y and Sekine J: Expression of aquaporin 3 and 5 as a potential marker for distinguishing dry mouth from Sjögren's syndrome. J Oral Sci. 60:212–220. 2018.PubMed/NCBI View Article : Google Scholar | |
|
Chow HH, Cai Y, Hakim IA, Crowell JA, Shahi F, Brooks CA, Dorr RT, Hara Y and Alberts DS: Pharmacokinetics and safety of green tea polyphenols after multiple-dose administration of epigallocatechin gallate and polyphenon E in healthy individuals. Clin Cancer Res. 9:3312–3319. 2003.PubMed/NCBI | |
|
Fürst R and Zündorf I: Plant-derived anti-inflammatory compounds: Hopes and disappointments regarding the translation of preclinical knowledge into clinical progress. Mediators Inflamm. 2014(146832)2014.PubMed/NCBI View Article : Google Scholar | |
|
Wyganowska-Świątkowska M, Matthews-Kozanecka M, Matthews-Brzozowska T, Skrzypczak-Jankun E and Jankun J: Can EGCG alleviate symptoms of down syndrome by altering proteolytic activity? Int J Mol Sci. 19(248)2018.PubMed/NCBI View Article : Google Scholar | |
|
Yan X, Li Y, Yu H, Wang W, Wu C, Yang Y, Hu Y, Shi X and Li J: Epigallocatechin-3-gallate inhibits H2O2-induced apoptosis in mouse vascular smooth muscle cells via 67kD laminin receptor. Sci Rep. 7(7774)2017.PubMed/NCBI View Article : Google Scholar | |
|
Wyganowska-Swiatkowska M, Nohawica M, Grocholewicz K and Nowak G: Influence of herbal medicines on HMGB1 release, SARS-CoV-2 viral attachment, acute respiratory failure, and sepsis. A literature review. Int J Mol Sci. 21(4639)2020.PubMed/NCBI View Article : Google Scholar | |
|
Soldatenkov VA and Smulson M: Poly(ADP-ribose) polymerase in DNA damage-response pathway: Implications for radiation oncology. Int J Cancer. 90:59–67. 2000.PubMed/NCBI View Article : Google Scholar | |
|
Zhang Y, Duan W, Owusu L, Wu D and Xin Y: Epigallocatechin-3-gallate induces the apoptosis of hepatocellular carcinoma LM6 cells but not non-cancerous liver cells. Int J Mol Med. 35:117–124. 2015.PubMed/NCBI View Article : Google Scholar | |
|
Harakeh S, Abu-El-Ardat K, Diab-Assaf M, Niedzwiecki A, El-Sabban M and Rath M: Epigallocatechin-3-gallate induces apoptosis and cell cycle arrest in HTLV-1-positive and -negative leukemia cells. Med Oncol. 25:30–39. 2008.PubMed/NCBI View Article : Google Scholar | |
|
Lancaster OM and Baum B: Shaping up to divide: Coordinating actin and microtubule cytoskeletal remodelling during mitosis. Semin Cell Dev Biol. 34:109–115. 2014.PubMed/NCBI View Article : Google Scholar | |
|
Desouza M, Gunning PW and Stehn JR: The actin cytoskeleton as a sensor and mediator of apoptosis. Bioarchitecture. 2:75–87. 2012.PubMed/NCBI View Article : Google Scholar | |
|
Mayr C, Wagner A, Neureiter D, Pichler M, Jakab M, Illig R, Berr F and Kiesslich T: The green tea catechin epigallocatechin gallate induces cell cycle arrest and shows potential synergism with cisplatin in biliary tract cancer cells. BMC Complement Altern Med. 15(194)2015.PubMed/NCBI View Article : Google Scholar | |
|
Yang CS, Lee MJ and Chen L: Human salivary tea catechin levels and catechin esterase activities: Implication in human cancer prevention studies. Cancer Epidemiol Biomarkers Prev. 8:83–89. 1999.PubMed/NCBI | |
|
Wheeler DS, Catravas JD, Odoms K, Denenberg A, Malhotra V and Wong HR: Epigallocatechin-3-gallate, a green tea-derived polyphenol, inhibits IL-1 beta-dependent proinflammatory signal transduction in cultured respiratory epithelial cells. J Nutr. 134:1039–1044. 2004.PubMed/NCBI View Article : Google Scholar | |
|
Ahn SC, Kim GY, Kim JH, Baik SW, Han MK, Lee HJ, Moon DO, Lee CM, Kang JH, Kim BH, et al: Epigallocatechin-3-gallate, constituent of green tea, suppresses the LPS-induced phenotypic and functional maturation of murine dendritic cells through inhibition of mitogen-activated protein kinases and NF-kappaB. Biochem Biophys Res Commun. 313:148–155. 2004.PubMed/NCBI View Article : Google Scholar | |
|
Saito K, Mori S, Date F and Hong G: Epigallocatechin gallate stimulates the neuroreactive salivary secretomotor system in autoimmune sialadenitis of MRL-Fas(lpr) mice via activation of cAMP-dependent protein kinase A and inactivation of nuclear factor κB. Autoimmunity. 48:379–388. 2015.PubMed/NCBI View Article : Google Scholar | |
|
Schieven GL: The biology of p38 kinase: A central role in inflammation. Curr Top Med Chem. 5:921–928. 2005.PubMed/NCBI View Article : Google Scholar | |
|
Stillman A, Connors M, Miller M, Qazzaz H and Dryden G: P-145 oral administration of EGCG, a green tea polyphenol, both suppresses and rescues mice from DSS-induced colitis. Inflamm Bowel Dis. 22:S54. 2016. | |
|
Sakai M, Ohnishi K, Masuda M, Ohminami H, Yamanaka-Okumura H, Hara T and Taketani Y: Isorhamnetin, a 3'-methoxylated flavonol, enhances the lysosomal proteolysis in J774.1 murine macrophages in a TFEB-independent manner. Biosci Biotechnol Biochem. 84:1221–1231. 2020.PubMed/NCBI View Article : Google Scholar | |
|
Holczer M, Besze B, Zámbó V, Csala M, Bánhegyi G and Kapuy O: Epigallocatechin-3-Gallate (EGCG) promotes autophagy-dependent survival via influencing the balance of mTOR-AMPK pathways upon endoplasmic reticulum stress. Oxid Med Cell Longev. 2018(e6721530)2018.PubMed/NCBI View Article : Google Scholar | |
|
Zhang S, Cao M and Fang F: The role of Epigallocatechin-3-Gallate in autophagy and endoplasmic reticulum stress (ERS)-induced apoptosis of human diseases. Med Sci Monit. 26(e924558)2020.PubMed/NCBI View Article : Google Scholar | |
|
Zhang L, Wang H, Xu J, Zhu J and Ding K: Inhibition of cathepsin S induces autophagy and apoptosis in human glioblastoma cell lines through ROS-mediated PI3K/AKT/mTOR/p70S6K and JNK signaling pathways. Toxicol Lett. 228:248–259. 2014.PubMed/NCBI View Article : Google Scholar | |
|
Hamm-Alvarez SF, Janga SR, Edman MC, Madrigal S, Shah M, Frousiakis SE, Renduchintala K, Zhu J, Bricel S, Silka K, et al: Tear cathepsin S as a candidate biomarker for Sjögren's syndrome. Arthritis Rheumatol. 66:1872–1881. 2014.PubMed/NCBI View Article : Google Scholar | |
|
Zhang B, Wang B, Cao S and Wang Y: Epigallocatechin-3-Gallate (EGCG) attenuates traumatic brain injury by inhibition of edema formation and oxidative stress. Korean J Physiol Pharmacol. 19:491–497. 2015.PubMed/NCBI View Article : Google Scholar | |
|
Ge R, Zhu Y, Diao Y, Tao L, Yuan W and Xiong X: Anti-edema effect of epigallocatechin gallate on spinal cord injury in rats. Brain Res. 1527:40–46. 2013.PubMed/NCBI View Article : Google Scholar | |
|
Kim JE, Park H, Jeong MJ and Kang TC: Epigallocatechin-3-Gallate and PEDF 335 peptide, 67LR activators, attenuate vasogenic edema, and astroglial degeneration following status epilepticus. Antioxidants (Basel). 9(854)2020.PubMed/NCBI View Article : Google Scholar | |
|
Nakamura Y, Tsuchiya T, Hara-Chikuma M, Yasui M and Fukui Y: Identification of compounds in red wine that effectively upregulate aquaporin-3 as a potential mechanism of enhancement of skin moisturizing. Biochem Biophys Rep. 24(100864)2020.PubMed/NCBI View Article : Google Scholar | |
|
Wang X, Yang L, Wang J, Zhang Y, Dong R, Wu X, Yang CS, Zhang Z and Zhang J: A mouse model of subacute liver failure with ascites induced by step-wise increased doses of (-)-epigallocatechin-3-gallate. Sci Rep. 9(18102)2019.PubMed/NCBI View Article : Google Scholar | |
|
Yan C, Yang J, Shen L and Chen X: Inhibitory effect of Epigallocatechin gallate on ovarian cancer cell proliferation associated with aquaporin 5 expression. Arch Gynecol Obstet. 285:459–467. 2012.PubMed/NCBI View Article : Google Scholar | |
|
Tepedelen BE, Soya E and Korkmaz M: Epigallocatechin-3-gallate reduces the proliferation of benign prostatic hyperplasia cells via regulation of focal adhesions. Life Sci. 191:74–81. 2017.PubMed/NCBI View Article : Google Scholar | |
|
Fong-Ngern K, Vinaiphat A and Thongboonkerd V: Microvillar injury in renal tubular epithelial cells induced by calcium oxalate crystal and the protective role of epigallocatechin-3-gallate. FASEB J. 31:120–131. 2017.PubMed/NCBI View Article : Google Scholar | |
|
Magro F, Fraga S and Soares-da-Silva P: Interferon-gamma-induced STAT1-mediated membrane retention of NHE1 and associated proteins ezrin, radixin and moesin in HT-29 cells. Biochem Pharmacol. 70:1312–1319. 2005.PubMed/NCBI View Article : Google Scholar | |
|
Meng M, Li YQ, Yan MX, Kou Y and Ren HB: Effects of epigallocatechin gallate on diethyldithiocarbamate-induced pancreatic fibrosis in rats. Biol Pharm Bull. 30:1091–1096. 2007.PubMed/NCBI View Article : Google Scholar | |
|
Higashi N, Kohjima M, Fukushima M, Ohta S, Kotoh K, Enjoji M, Kobayashi N and Nakamuta M: Epigallocatechin-3-gallate, a green-tea polyphenol, suppresses Rho signaling in TWNT-4 human hepatic stellate cells. J Lab Clin Med. 145:316–322. 2005.PubMed/NCBI View Article : Google Scholar | |
|
Asaumi H, Watanabe S, Taguchi M, Tashiro M, Nagashio Y, Nomiyama Y, Nakamura H and Otsuki M: Green tea polyphenol (-)-epigallocatechin-3-gallate inhibits ethanol-induced activation of pancreatic stellate cells. Eur J Clin Invest. 36:113–122. 2006.PubMed/NCBI View Article : Google Scholar | |
|
Cano A, Ettcheto M, Chang JH, Barroso E, Espina M, Kühne BA, Barenys M, Auladell C, Folch J, Souto EB, et al: Dual-drug loaded nanoparticles of Epigallocatechin-3-gallate (EGCG)/Ascorbic acid enhance therapeutic efficacy of EGCG in a APPswe/PS1dE9 Alzheimer's disease mice model. J Control Release. 301:62–75. 2019.PubMed/NCBI View Article : Google Scholar | |
|
Qiu J, Kitamura Y, Miyata Y, Tamaru S, Tanaka K, Tanaka T and Matsui T: Transepithelial transport of theasinensins through Caco-2 cell monolayers and their absorption in Sprague-Dawley rats after oral administration. J Agric Food Chem. 60:8036–8043. 2012.PubMed/NCBI View Article : Google Scholar | |
|
Lagha AB and Grenier D: Tea polyphenols protect gingival keratinocytes against TNF-α-induced tight junction barrier dysfunction and attenuate the inflammatory response of monocytes/macrophages. Cytokine. 115:64–75. 2019.PubMed/NCBI View Article : Google Scholar | |
|
Li J, Ye L, Wang X, Liu J, Wang Y, Zhou Y and Ho W: (-)-Epigallocatechin gallate inhibits endotoxin-induced expression of inflammatory cytokines in human cerebral microvascular endothelial cells. J Neuroinflammation. 9(161)2012.PubMed/NCBI View Article : Google Scholar | |
|
Lagha AB, Groeger S, Meyle J and Grenier D: Green tea polyphenols enhance gingival keratinocyte integrity and protect against invasion by Porphyromonas gingivalis. Pathog Dis. 76:2018.PubMed/NCBI View Article : Google Scholar | |
|
Watson JL, Ansari S, Cameron H, Wang A, Akhtar M and McKay DM: Green tea polyphenol (-)-epigallocatechin gallate blocks epithelial barrier dysfunction provoked by IFN-gamma but not by IL-4. Am J Physiol Gastrointest Liver Physiol. 287:G954–961. 2004.PubMed/NCBI View Article : Google Scholar | |
|
Suzuki T and Hara H: Role of flavonoids in intestinal tight junction regulation. J Nutr Biochem. 22:401–408. 2011.PubMed/NCBI View Article : Google Scholar | |
|
Amerongen AV, Bolscher JG and Veerman EC: Salivary mucins: Protective functions in relation to their diversity. Glycobiology. 5:733–740. 1995.PubMed/NCBI View Article : Google Scholar | |
|
Alliende C, Kwon YJ, Brito M, Molina C, Aguilera S, Pérez P, Leyton L, Quest AF, Mandel U, Veerman E, et al: Reduced sulfation of muc5b is linked to xerostomia in patients with Sjögren syndrome. Ann Rheum Dis. 67:1480–1487. 2008.PubMed/NCBI View Article : Google Scholar | |
|
Xu H, Shan XF, Cong X, Yang NY, Wu LL, Yu GY, Zhang Y and Cai ZG: Pre- and post-synaptic effects of botulinum toxin A on submandibular glands. J Dent Res. 94:1454–1462. 2015.PubMed/NCBI View Article : Google Scholar | |
|
Besserer A, Burnotte E, Bienert GP, Chevalier AS, Errachid A, Grefen C, Blatt MR and Chaumont F: Selective regulation of maize plasma membrane aquaporin trafficking and activity by the SNARE SYP121. Plant Cell. 24:3463–3481. 2012.PubMed/NCBI View Article : Google Scholar | |
|
Noda Y, Horikawa S, Kanda E, Yamashita M, Meng H, Eto K, Li Y, Kuwahara M, Hirai K, Pack C, et al: Reciprocal interaction with G-actin and tropomyosin is essential for aquaporin-2 trafficking. J Cell Biol. 182:587–601. 2008.PubMed/NCBI View Article : Google Scholar | |
|
Beroukas D, Hiscock J, Jonsson R, Waterman SA and Gordon TP: Subcellular distribution of aquaporin 5 in salivary glands in primary Sjögren's syndrome. Lancet. 358:1875–1876. 2001.PubMed/NCBI View Article : Google Scholar | |
|
Nashida T, Yoshie S, Haga-Tsujimura M, Imai A and Shimomura H: Atrophy of myoepithelial cells in parotid glands of diabetic mice; detection using skeletal muscle actin, a novel marker. FEBS Open Bio. 3:130–134. 2013.PubMed/NCBI View Article : Google Scholar | |
|
Mei M, Xiang RL, Cong X, Zhang Y, Li J, Yi X, Park K, Han JY, Wu LL and Yu GY: Claudin-3 is required for modulation of paracellular permeability by TNF-α through ERK1/2/slug signaling axis in submandibular gland. Cell Signal. 27:1915–1927. 2015.PubMed/NCBI View Article : Google Scholar | |
|
Cong X, Zhang XM, Zhang Y, Wei T, He QH, Zhang LW, Hua H, Lee SW, Park K, Yu GY and Wu LL: Disruption of endothelial barrier function is linked with hyposecretion and lymphocytic infiltration in salivary glands of Sjögren's syndrome. Biochim Biophys Acta Mol Basis Dis. 1864:3154–3163. 2018.PubMed/NCBI View Article : Google Scholar |
